Aspira Women's Health Inc.
AWHL· OTC
Released Nov 12, 2020, after the close
10-Q filed Nov 12, 2020, 43 days after period end · 0000926617-20-000079
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $1.24M | $1.29M | $774.00K | $699.00K |
| Net Income | -$4.29M | -$3.82M | -$2.65M | -$2.51M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.04 |
| -$0.04 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.